Patricia Ann Basford,Anthony Michael Campeta,Adam Gillmore,Matthew Cameron Jones,Eleftherios Kougoulos,Suman Luthra,Robert Walton
申请号：
US14698463
公开号：
US20150238504A1
申请日:
2015.04.28
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.
